TRADE WITH CONVICTION

Tuesday, August 18, 2026
RSS

Marcus Rivera

The Street Storyteller

Newsletter Writer
Markets

HomeTrust’s Virginia Bet Puts Regional-Bank Consolidation Back in Focus

HomeTrust’s acquisition of Blue Ridge Bankshares expands $HTB into Virginia and gives $BRBS sharehol…

Aug 17, 2026
Analysis

Fulcrum-Slate Merger Puts Migraine Strategy in the Spotlight for FULC Investors

Fulcrum’s planned merger with Slate Medicines shifts the spotlight to next-generation migraine thera…

Aug 17, 2026
Analysis

Reddit’s 13% Surge Shows the Trading Power of S&P 500 Index Inclusion

Reddit’s almost 13% jump highlights how S&P 500 additions can attract momentum traders and potential…

Aug 16, 2026
Analysis

Diana Shipping Ends Genco Bid After $36.91-Per-Share Valuation Clash

Diana Shipping withdrew its Genco bid after the board sought about $36.91 per share, raising fresh q…

Aug 15, 2026
Markets

Star Equity’s $5 Harte-Hanks Deal Puts Merger Arbitrage in the Spotlight

Star Equity plans to acquire Harte-Hanks for $5 per share in cash, creating a merger-arbitrage setup…

Aug 14, 2026
Economy

Charter-Cox Merger Clears Final Major State Hurdle With California Approval

California’s approval removes a major state obstacle for Charter’s Cox merger, bringing the transact…

Aug 14, 2026
Analysis

Rocket Lab’s Iridium Deal Clears Antitrust Hurdle as RKLB Advances Toward Closing

Rocket Lab’s Iridium acquisition clears the HSR waiting period as Form S-4, FCC filings and financin…

Aug 13, 2026
Economy

10-Year Treasury Yield Slips to 4.674% as PPI Becomes Wall Street’s Next Rate Catalyst

The 10-year yield eased to 4.674% as traders await PPI, weighing inflation, oil, the dollar and Midd…

Aug 13, 2026
Economy

Stocks Test Records After In-Line July CPI Keeps Equity Bulls in Control

In-line July CPI eased a key inflation worry as the S&P 500 tested its record, but traders now face …

Aug 12, 2026
Analysis

Cardinal Health Price Target Raised on Strong Profitability Outlook Despite Uneven Quarter

Cardinal Health’s uneven quarter took a back seat to rosy forward profitability guidance, prompting …

Aug 12, 2026
Analysis

Aurora Cannabis Shares Jump as Curaleaf Plans Takeover Offer

Aurora Cannabis shares jumped after Curaleaf said it will make a formal takeover offer, putting cros…

Aug 11, 2026
Analysis

Nvidia’s Next AI Financing Idea Could Test the Durability of the AI Trade

Wall Street has endorsed Jensen Huang’s AI infrastructure concept, but the undisclosed mechanics may…

Aug 11, 2026
Analysis

IES Holdings’ $650 Million DBM Global Deal Expands Its Structural Steel Footprint

IES Holdings is adding DBM Global as a new Structural business, while INNOVATE monetizes a major ass…

Aug 10, 2026
Economy

S&P 500 Futures Gain 0.6% as Stocks Extend Best Weekly Run Since April

U.S. stocks carry powerful momentum into Monday, but strategists warn July’s pullback may not have f…

Aug 10, 2026
Analysis

Celsius Stock Jumps as Rockstar Founder Builds 4.7% Stake and Seeks CEO Role

Rockstar founder Russ Savage disclosed a 4.7% Celsius stake and said he wants to become CEO, creatin…

Aug 9, 2026
Analysis

Celsius Stock Jumps as Rockstar Founder Russ Savage Reveals 4.7% Stake and CEO Ambition

Russ Savage’s 4.7% Celsius stake and CEO ambitions turn a trading catalyst into a potential corporat…

Aug 8, 2026
Markets

Dream Finders' $2.2 Billion Beazer Deal Puts Homebuilder Consolidation in Focus

Dream Finders' $2.2B all-cash Beazer acquisition, backed by up to $1.25B from Millrose, highlights c…

Aug 7, 2026
Analysis

Dream Finders’ $2.2 Billion Beazer Homes Deal Puts Homebuilder Consolidation in Focus

Dream Finders’ $2.2 billion all-cash purchase of Beazer Homes puts financing, scale and US homebuild…

Aug 7, 2026
Analysis

Virginia Intervention Threatens to Complicate NextEra-Dominion Merger

Virginia’s planned intervention adds state-level regulatory uncertainty to the proposed NEE-D merger…

Aug 6, 2026
IPO

Tarsus to Acquire Alkeus, Adding Phase 3 Stargardt Disease Drug Candidate

Tarsus is acquiring Alkeus and its Phase 3 Stargardt disease candidate ALK-001, while Harrow’s TYRVA…

Aug 6, 2026